Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson’s Disease

April 26, 2011 By Bio-Medicine.Org

INDIANAPOLIS and MINNEAPOLIS, April 26, 2011 /PRNewswire/ — Eli
Lilly and Company (NYSE:
LLY
) and Medtronic, Inc. (NYSE:
MDT
) today announced they have entered into a collaboration to
research and develop a new approach to treating Parkinson’s disease
that involves delivering a potential new  medicine to the
brain using an implantable drug delivery system. The goal of the
collaboration is to develop a therapeutic approach for Parkinson’s
disease that combines the strengths of Lilly’s biologic, a modified
form of glial cell derived neurotrophic factor (GDNF), with
Medtronic’s implantable drug infusion system technology.

“We believe we have biosynthetically engineered this GDNF
variant to overcome technical hurdles of previous research in this
area and are hopeful that early testing of our biologic with
Medtronic’s device will provide the necessary data to safely
advance into human studies,” said Michael L. Hutton, Ph.D., chief
scientific officer of the neurodegeneration team at Lilly. “By
collaborating with Medtronic from the earliest phase of research,
we are maximizing the potential for this therapy’s efficient and
effective development.”

Parkinson’s disease is a neurodegenerative condition caused by
progressive loss of neurons in the brain that produce dopamine, a
chemical messenger responsible for transmitting signals that allow
for coordination of movement. As a result, patients with
Parkinson’s disease experience balance problems, tremors and
muscular stiffness, among other symptoms which worsen over time.
 It is estimated that 7 million to 10 million people worldwide
are living with Parkinson’s disease(i) and there is no cure. Around
the world, April is Parkinson’s Awareness Month.

Applying its expertise in biotechnology, Lilly has designed its
GDNF variant with th

‘/>”/>

SOURCE

Related Articles Read More >

DeepWell Digital Therapeutics Mike Wilson Ryan Douglas
How DeepWell is developing video games as tools for treating medical conditions
A woman with a small, handheld device in her lap with tubes that look like earphones plugged into her ears.
Ear-puffing device for migraine treatment wins FDA breakthrough designation
Abbott
Abbott launches upgraded digital health app for neurostimulation
Catheter delivery could enable better brain implants: Synchron’s neuroscience chief explains how

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech